Trump Appoints Stanford Professor and COVID Lockdown Critic to Head Health Agency
November 28, 2024 - 08:51
In a significant move, former President Donald Trump has selected a Stanford University professor known for his critical stance on COVID-19 lockdowns to lead a key health agency. This appointment comes as part of Trump’s ongoing efforts to reshape health policy and address public health challenges in the wake of the pandemic. The professor, who has gained attention for advocating against strict lockdown measures, is expected to bring a controversial perspective to the role.
Before officially assuming the position, the appointee will need to secure confirmation from the U.S. Senate, a process that could spark intense debate given the professor's previous comments and the current political climate surrounding public health policies. Trump's choice reflects his commitment to appointing individuals who align with his views on government intervention and public health measures. As the nation continues to navigate the complexities of health care and pandemic response, this appointment is poised to influence future strategies and discussions within the health sector.
MORE NEWS
July 22, 2026 - 08:37
Bradford A&E services downgraded by health watchdogA health watchdog has downgraded the accident and emergency services at Bradford Royal Infirmary following an inspection that uncovered significant concerns. The Care Quality Commission (CQC) found...
July 21, 2026 - 17:42
Rare disease drugmakers try to avoid Trump price cutsPharmaceutical companies that specialize in treatments for rare diseases are scrambling to shield their products from possible price cuts under a potential second Trump administration. During his...
July 21, 2026 - 06:41
The rise of Zyn-like pouches for sleep, health, focus, teethThe success of Zyn nicotine pouches has sparked a wave of copycat products that promise to deliver everything from better sleep to sharper focus, all through a small pouch tucked inside the lip....
July 20, 2026 - 19:14
FDA says it’s still investigating Taylor Farms in cyclosporiasis outbreakThe U.S. Food and Drug Administration has clarified that a false-positive lab result does not alter the `overwhelming epidemiological data` pointing to Taylor Farms as the source of a...